Nanova, Inc. Columbia, MO 65211, USA.
Int J Mol Sci. 2013 Sep 6;14(9):18488-501. doi: 10.3390/ijms140918488.
Biofilm formation by human bacterial pathogens on implanted medical devices causes major morbidity and mortality among patients, and leads to billions of dollars in healthcare cost. Biofilm is a complex bacterial community that is highly resistant to antibiotics and human immunity. As a result, novel therapeutic solutions other than the conventional antibiotic therapies are in urgent need. In this review, we will discuss the recent research in discovery of alternative approaches to prevent or treat biofilms. Current anti-biofilm technologies could be divided into two groups. The first group focuses on targeting the biofilm forming process of bacteria based on our understanding of the molecular mechanism of biofilm formation. Small molecules and enzymes have been developed to inhibit or disrupt biofilm formation. Another group of anti-biofilm technologies focuses on modifying the biomaterials used in medical devices to make them resistant to biofilm formation. While these novel anti-biofilm approaches are still in nascent phases of development, efforts devoted to these technologies could eventually lead to anti-biofilm therapies that are superior to the current antibiotic treatment.
人体细菌病原体在植入性医疗设备上形成生物膜会导致患者发病率和死亡率大幅上升,并导致数十亿美元的医疗保健费用。生物膜是一种复杂的细菌群落,对抗生素和人体免疫具有很强的抵抗力。因此,除了传统的抗生素治疗方法外,急需新的治疗方法。在这篇综述中,我们将讨论最近在发现预防或治疗生物膜的替代方法方面的研究进展。目前的抗生物膜技术可以分为两类。第一组方法侧重于基于对生物膜形成机制的理解,针对细菌的生物膜形成过程。已经开发出小分子和酶来抑制或破坏生物膜的形成。另一组抗生物膜技术侧重于修饰用于医疗器械的生物材料,使它们不易形成生物膜。虽然这些新型抗生物膜方法仍处于发展的初期阶段,但这些技术的努力最终可能会导致优于当前抗生素治疗的抗生物膜疗法。